Drug Development

Articles

The company says the new equipment will reduce sample turnaround times and increase variant detection quality and accuracy.

Almac Invests in Next-Generation Sequencing Capabilities

Advances in biologic drug development require increased methodological and technological innovation from the biopharma industry. Learn more at the new bioLIVE launching this year adjacent to CPhI Worldwide 2018.

Biologic Drugs Challenge the Biopharma Industry

Lonza’s Capsugel Colorista capsule R&D solution can cut overall development time and offers greater flexibility during technical color development.

New Capsule R&D Solution

Funding from Innovate UK will be used by Medherant to support manufacture of transdermal patches for clinical trials.

Medherant Receives Grant from Innovate UK for Transdermal Patch Manufacturing

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

The Global Health division of the Bill and Melinda Gates Foundation is seeking solutions for health problems, such as infectious diseases, that impact the developing world, including identifying drug delivery forms to compensate for a lack of infrastructure in these regions.

Drug Delivery Innovation Funded by the Gates Foundation

Innovative technologies, such as drug-loaded devices and 3D printing, enable advances in implantable devices and other novel dosage forms.

New Dose Forms Focus on the Patient

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Lipid-based formulations offer a means of addressing the physicochemical and biological challenges of poorly soluble APIs.

Developing Lipid-Based Formulations

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

Industry experts discuss the formulation and development issues that should be considered when addressing scale up from small-scale batches to commercial production.

Outsourcing Development: Small-Scale to Commercial

Specialist biopharmaceutical company, Alvotech, has announced receipt of a manufacturing license from the Icelandic Medicines Agency, applying to its biopharmaceutical facility based in Reykjavik, Iceland.

Manufacturing License Granted to Alvotech for Biopharma Facility

CPhI releases the bio trends portion of its annual report, which predicts an increase in bioconjucation expertise and biopharma productivity over the next five years. 

Formulation and Drug Delivery